AwardedCzechiaGoodsCZK 201,250,000
Léčivé přípravky s obsahem dostarlimabu, enfortumab vedotinu, gemtuzumab ozogamicinu, glofitamabu, nivolumabu a relatlimabu, panitumumabu, ramucirumabu
- Published
- Published 14 April 2025
- Deadline
- Closed 19 May 2025
Overview
Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem dostarlimabu, enfortumab vedotinu, gemtuzumab ozogamicinu, glofitamabu, nivolumabu a relatlimabu, panitumumabu, ramucirumabu po dobu 4 let dle aktuálních potřeb zadavatele.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 201,250,000
- Procedure
- Open
- Published
- 14 April 2025
- Deadline
- Closed
Antineoplastic agents
Award outcome
- Awarded value
- CZK 129,097,980
- Award date
- 4 June 2025
- Contract period
- 19 June 2025 → 18 June 2029
- Amgen s.r.o.
- GlaxoSmithKline, s.r.o.
- PHOENIX lékárenský velkoobchod, s.r.o.
- ROCHE s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
11 July 2025
Contract Award Notice
18 June 2025
Contract Notice
22 April 2025
Contract Notice
14 April 2025
Contracting authority
Fakultní nemocnice Hradec Králové
Procuring entityHradec Králové - Nový Hradec Králové, Czechia
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.